Kosmas C - Search Results

1

Leucovorin and 5-fluorouracil versus levamisole and 5-fluorouracil as adjuvant chemotherapy in rectal cancer.

Tsavaris N, Genatas K, Kosmas C, Skopelitis HM, Dimitrakopoulos A, Zacharakis M, Kouraklis G, Zografos G, Macheras A, Diamantis N, Diamantis T, Chalkias S, Tsaousi S, Papastratis G, Karatzas G, Papalambros E. Tsavaris N, et al. Among authors: kosmas c. J BUON. 2005 Oct-Dec;10(4):499-504. J BUON. 2005. PMID: 17357207

2

Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study.

Tsavaris N, Kosmas CH, Vadiaka M, Kontos A, Katsorida M, Dimitrakopoulos A, Zerai A, Koufos CH. Tsavaris N, et al. Among authors: kosmas ch. J Exp Clin Cancer Res. 2001 Mar;20(1):29-34. J Exp Clin Cancer Res. 2001. PMID: 11370826 Clinical Trial.

3

A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.

Kosmas C, Tsavaris NB, Makatsoris T, Onyenadum A, Vadiaka M, Stavroyianni N, Sepsas E, Dimitropoulos D, Rokana S, Kalofonos HP. Kosmas C, et al. Int J Cancer. 2002 Mar 1;98(1):141-7. doi: 10.1002/ijc.10162. Int J Cancer. 2002. PMID: 11857398 Clinical Trial.

4

Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy.

Tsavaris N, Kosmas C, Vadiaka M, Koufos C. Tsavaris N, et al. Among authors: kosmas c. BMC Cancer. 2002;2:2. doi: 10.1186/1471-2407-2-2. Epub 2002 Jan 30. BMC Cancer. 2002. PMID: 11860608 Free PMC article. Clinical Trial.

5

Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer.

Kosmas C, Malamos NA, Tsavaris NB, Stamataki M, Stefanou S, Gregoriou A, Rokana S, Vartholomeou M, Antonopoulos MJ. Kosmas C, et al. J Neurooncol. 2002 Feb;56(3):265-73. doi: 10.1023/a:1015018808804. J Neurooncol. 2002. PMID: 12061734

6

Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.

Tsavaris N, Kosmas C, Vadiaka M, Efremidis M, Zinelis A, Beldecos D, Sakelariou D, Koufos C, Stamatelos G. Tsavaris N, et al. Among authors: kosmas c. Med Sci Monit. 2002 Jun;8(6):PI51-7. Med Sci Monit. 2002. PMID: 12070449

7

Salvage chemotherapy with the gemcitabine/docetaxel combination in non-small cell lung cancer: an overview of recent phase II studies.

Kosmas C, Tsavaris N, Kalofonos HP. Kosmas C, et al. Med Sci Monit. 2002 Jun;8(6):PI58-63. Med Sci Monit. 2002. PMID: 12070450

8

Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stages III/IV) non-Hodgkin's lymphoma.

Tsavaris N, Kosmas C, Vadiaka M, Giannouli S, Siakantaris MP, Vassilakopoulos T, Pangalis GA. Tsavaris N, et al. Among authors: kosmas c. Anticancer Res. 2002 May-Jun;22(3):1845-8. Anticancer Res. 2002. PMID: 12168880 Clinical Trial.

9

Isolated leptomeningeal carcinomatosis (carcinomatous meningitis) after taxane-induced major remission in patients with advanced breast cancer.

Kosmas C, Malamos NA, Tsavaris NB, Stamataki M, Gregoriou A, Rokana S, Vartholomeou M, Antonopoulos MJ. Kosmas C, et al. Oncology. 2002;63(1):6-15. doi: 10.1159/000065714. Oncology. 2002. PMID: 12187065 Clinical Trial.

10

Etoposide added to weekly leucovorin (LV)/5-fluorouracil (5-FU) in LV/5-FU pre-treated patients with advanced colorectal cancer.

Tsavaris N, Kosmas C, Gennatas K, Vadiaka M, Paliaros P, Dimitrakopoulos A, Diamantis T, Tsipras H, Papastratis G. Tsavaris N, et al. Among authors: kosmas c. Med Sci Monit. 2002 Sep;8(9):PI65-9. Med Sci Monit. 2002. PMID: 12218954 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters